Sanofi’s Sarclisa combination shows positive results in multiple myeloma patients
Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells
16th May 2022
Latest news
Positive results for AstraZeneca’s asthma therapy
PT027 is being developed through a partnership involving AstraZeneca and Avillion
16th May 2022
NHS patients missing out on new medicines that could extend lives
Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out
13th May 2022
NICE draft final guidance for Gedeon Richter UK’s new uterine fibroids treatment
The therapy offers patients a convenient alternative to surgery or injections and can be administered at home
13th May 2022
Superdrug launch comprehensive perimenopause screen service
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
12th May 2022
London Medical Laboratory’s tests show 80% of children may develop allergies if parents have them
The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens
12th May 2022
PrecisionLife and Sano Genetics partnership will help identify treatments for long COVID
The project will analyse risks from Sano Genetics’ data from 3,000 UK adults suffering from long COVID
11th May 2022
New data reinforces AstraZeneca and Sanofi’s nirsevimab as effective RSV immunisation
Nirsevimab is the first investigational immunisation designed to protect all infants across the RSV season with a single dose
11th May 2022
First treatment option indicated for CKD in Scotland for 20 years
NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy
10th May 2022
University of Aberdeen study finds diabetes almost doubles risk of COVID-19 death
Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes
10th May 2022
AbbVie and Cerebras Systems partner to accelerate AI research
Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption
9th May 2022
Evotenix receives patent for gene synthesis method
Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms
9th May 2022
University launches hub for pregnant women with pre-existing medical conditions
Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions
6th May 2022
WHO recommends Veklury for high-risk patients
WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions
6th May 2022
Farxiga demonstrates success in preserved ejection fraction trial
DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction
5th May 2022
